Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Aug;30(4):476-8.
doi: 10.1097/JCP.0b013e3181e5c168.

Reduced cannabis use after low-dose naltrexone addition to opioid detoxification

Paolo Mannelli, Kathi Peindl, Ashwin A Patkar, Li-Tzy Wu, Chi-Un Pae, David A Gorelick

Reduced cannabis use after low-dose naltrexone addition to opioid detoxification

Paolo Mannelli et al. J Clin Psychopharmacol. 2010 Aug.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest

No author has declared potential conflict of interest with the present work.

References

    1. Epstein DH, Preston KL. Does cannabis use predict poor outcome for heroin-dependent patients on maintenance treatment? Past findings and more evidence against. Addiction. 2003;98:269–279. - PMC - PubMed
    1. Raby WN, Carpenter KM, Rothenberg J, et al. Intermittent marijuana use is associated with improved retention in naltrexone treatment for opiate-dependence. Am J Addict. 2009;18:301–308. - PMC - PubMed
    1. Budney AJ, Roffman R, Stephens RS, et al. Marijuana dependence and its treatment. Addict Sci Clin Pract. 2007;4:4–16. - PMC - PubMed
    1. Haney M. Opioid antagonism of cannabinoid effects: differences between marijuana smokers and nonmarijuana smokers. Neuropsychopharmacology. 2007;32:1391–1403. - PubMed
    1. Mannelli P, Patkar AA, Peindl K, et al. Early outcomes following low dose naltrexone enhancement of opioid detoxification. Am J Addict. 2009;18:109–116. - PMC - PubMed

Publication types

MeSH terms

Associated data